| 000 -LEADER |
|---|
| fixed length control field |
01355cam a22002778a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20151021130104.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
100622s2010 ctu b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781607951087 |
|
|---|
| International Standard Book Number |
1607951088 |
| 041 ## - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC684.A35 |
| Item number |
C774 2010 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.106 |
| Edition number |
22 |
| Item number |
C774 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cruickshank, J. M. |
| 9 (RLIN) |
3912 |
| 245 14 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
The modern role of [beta]-blockers (BBS) in cardiovascular medicine / |
| Statement of responsibility, etc |
John Malcolm Cruickshank. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Shelton, Conn. : |
| Name of publisher, distributor, etc |
People's Medical Pub. House-USA, |
| Date of publication, distribution, etc |
2010. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiii, 271 p. : |
| Dimensions |
21 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Pharmacology -- [Beta]-blockers and their effects upon ischemic heart disease, peripheral vascular disease (including aortic aneurysms), noncardiac surgery (in high-risk cases), and the atheromatous process -- [Beta]-blockers and hypertension -- [Beta]-blockers and cardiac arrhythmias -- [Beta]-blockers and heart failure. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Adrenergic beta blockers |
| General subdivision |
Therapeutic use. |
| 9 (RLIN) |
3913 |
|
|---|
| Topical term or geographic name as entry element |
Cardiovascular system |
| General subdivision |
Diseases |
| -- |
Treatment. |
| 9 (RLIN) |
3914 |
|
|---|
| Topical term or geographic name as entry element |
Cardiovascular pharmacology. |
| 9 (RLIN) |
3915 |
|
|---|
| Topical term or geographic name as entry element |
Adrenergic beta-Antagonists |
| General subdivision |
therapeutic use. |
| 9 (RLIN) |
3916 |
|
|---|
| Topical term or geographic name as entry element |
Adrenergic beta-Antagonists |
| General subdivision |
pharmacology. |
| 9 (RLIN) |
3917 |
|
|---|
| Topical term or geographic name as entry element |
Cardiovascular Diseases |
| General subdivision |
drug therapy. |
| 9 (RLIN) |
3918 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
